Amer I. Aladin, MBCHB

Amer Aladin practices at Infinite Medical in West Palm Beach, Florida.

Amer Aladin's NPI, 1013127299, was assigned on May 23, 2007. Amer Aladin graduated from Other in 1998. Amer Aladin holds New Jersey license 25MA11853900.

Amer Aladin's primary practice is Infinite Medical, at 534 Datura St, West Palm Beach, FL 33401 in Palm Beach County. The practice phone is (718) 964-6161.

Amer Aladin's primary practice is Infinite Medical in West Palm Beach, Florida. Amer Aladin is also affiliated with St. Mary's General Hospital. The medical group on file is St. Joseph's Health Medical Group. Dmand AI also links Amer Aladin to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amer Aladin practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Amer Aladin's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Amer Aladin's licenses on file in 2 states: New Jersey and North Carolina.

CMS data shows 228 Medicare services from Amer Aladin across 8 procedure codes in 2024, for 89 Medicare patients. Medicare paid $20,211 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Amer Aladin in 2024. The largest group is 75 to 84, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amer Aladin's median patient age at 75, with 50% women.

In 2024, Amer Aladin wrote 51 Medicare Part D claims. 51% of them were for generic drugs. CMS names the drug for 21 of them, across 1 drug with 11 or more claims each, at $9,357 in total drug cost. In 2021, CMS named 25 claims across 2 drugs.

Amer Aladin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Amer Aladin, published from 2014 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Percutaneous Coronary Intervention, Heart Rate and Transcatheter Aortic Valve Replacement. Amer Aladin has published most often in Am J Cardiol. Amer Aladin's most frequent co-authors are Ron Waksman, MD, Sukhdeep Singh Bhogal, MD and Shereen Hawal Rasool, MD.

CMS Open Payments shows 55 general payments to Amer Aladin from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 67% of the total. Abbott Laboratories paid the most, $464.

Amer Aladin graduated from Other in 1998.